SPDR S&P Pharmaceuticals ETF
XPH
XPH
61 hedge funds and large institutions have $154M invested in SPDR S&P Pharmaceuticals ETF in 2019 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 27 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
71% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 24
Holders
61
Holding in Top 10
–
Calls
$7K
Puts
–
Top Buyers
| 1 | +$9.84M | |
| 2 | +$1.22M | |
| 3 | +$706K | |
| 4 |
D.E. Shaw & Co
New York
|
+$673K |
| 5 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$495K |
Top Sellers
| 1 | -$12.4M | |
| 2 | -$5.97M | |
| 3 | -$4.71M | |
| 4 |
CI
Cavalier Investments
Alpharetta,
Georgia
|
-$2.3M |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$1.64M |